Blood biomarkers predicting disease progression in patients with IPF: data from the INMARK trial

被引：0
|
作者：
Prasse, A. [1 ]
Maher, T. M. [2 ,3 ]
Jenkins, R. G. [4 ]
Cottin, V [5 ]
Nishioka, Y. [6 ]
Noth, I [7 ]
Selman, M. [8 ]
Song, J. W. [9 ]
Ittrich, C. [10 ]
Diefenbach, C. [10 ]
Rohr, K. B. [11 ]
Stowasser, S. [11 ]
White, E. S. [12 ]
机构：
[1] MHH Hannover Med Sch, Dept Resp Med, Hannover, Germany
[2] Imperial Coll London, Natl Heart & Lung Inst, London, England
[3] Royal Brompton Hosp, Natl Inst Hlth Res Clin Res Facil, London, England
[4] Nottingham Univ Hosp, Natl Inst Hlth Res Resp Biomed Res Ctr, City Campus, Nottingham, England
[5] Claude Bernard Lyon 1 Univ, Louis Pradel Hosp, Natl Reference Ctr Rare Pulm Dis, Dept Resp Dis, Lyon, France
[6] Tokushima Univ, Grad Sch Biomed Sci, Tokushima, Japan
[7] Univ Virginia, Div Pulm & Crit Care Med, Charlottesville, VA USA
[8] Inst Nacl Enfermedades Resp, Mexico City, DF, Mexico
[9] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pulm & Crit Care Med, Seoul, South Korea
[10] Boehringer Ingelheim Pharma GmbH & Co Kg, Biberach, Germany
[11] Boehringer Ingelheim Int GmbH, Ingelheim, Germany
[12] Univ Michigan, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA
来源：
PNEUMOLOGIE | 2020年 / 74卷
关键词：
D O I：
10.1055/s-0039-3403294
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
P172
引用
收藏
页码：S104 / S104
页数：1
相关论文
共 50 条
  • [1] Blood biomarkers predicting disease progression in patients with IPF: data from the INMARK trial
    Maher, Toby
    Jenkins, Gisli
    Cottin, Vincent
    Nishioka, Yasuhiko
    Noth, Imre
    Selman, Moises
    Song, Jin Woo
    Prasse, Antje
    Ittrich, Carina
    Diefenbach, Claudia
    Rohr, Klaus B.
    Stowasser, Susanne
    White, Eric S.
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [2] Effect of nintedanib on blood biomarkers in patients with IPF in the INMARK trial
    Jenkins, Gisli
    Maher, Toby M.
    Cottin, Vincent
    Nishioka, Yasuhiko
    Noth, Imre
    White, Eric S.
    Ittrich, Carina
    Diefenbach, Claudia
    Rohr, Klaus B.
    Stowasser, Susanne
    Selman, Moises
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [3] Circulating biomarkers and progression of idiopathic pulmonary fibrosis: data from the INMARK trial
    Maher, Toby M.
    Jenkins, R. Gisli
    Cottin, Vincent
    Nishioka, Yasuhiko
    Noth, Imre
    Selman, Moises
    Song, Jin Woo
    Ittrich, Carina
    Diefenbach, Claudia
    Stowasser, Susanne
    White, Eric S.
    ERJ OPEN RESEARCH, 2024, 10 (04)
  • [4] Adherence to home spirometry among patients with IPF: results from the INMARK trial
    Noth, Imre
    Maher, Toby M.
    Johannson, Kerri A.
    Chaudhuri, Nazia
    Jouneau, Stephane
    Michael, Andreas
    Rohr, Klaus B.
    Quaresma, Manuel
    Stowasser, Susanne
    Cottin, Vincent
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [5] Effects of nintedanib on markers of epithelial damage in subjects with IPF: data from the INMARK trial
    Jenkins, Gisli
    Noth, Imre
    Selman, Moises
    Cottin, Vincent
    Nishioka, Yasuhiko
    Song, Jin Woo
    Prasse, Antje
    White, Eric S.
    Ittrich, Carina
    Diefenbach, Claudia
    Rohr, Klaus B.
    Stowasser, Susanne
    Maher, Toby M.
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [6] Investigating effects of nintedanib on biomarkers of ECM turnover in patients with IPF: the INMARK study
    Maher, Toby
    Stowasser, Susanne
    Nishioka, Yasuhiko
    White, Eric S.
    Cottin, Vincent
    Noth, Imre
    Selman, Moises
    Wachtlin, Daniel
    Diefenbach, Claudia
    Jenkins, R. Gisli
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [7] Peripheral Blood Biomarkers Predict Disease Progression And Mortality In IPF
    Richards, T. J.
    Lindell, K. O.
    Klesen, M.
    Kaminski, N.
    Zhang, Y.
    Gibson, K. F.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [8] Gene Expression Profiling in Patients with Idiopathic Pulmonary Fibrosis (IPF) in the INMARK Trial
    Selman, M.
    Jenkins, R. G.
    White, E. S.
    Cottin, V.
    Nishioka, Y.
    Noth, I.
    Prasse, A.
    Song, J.
    Strobel, B.
    Leparc, G.
    Ittrich, C.
    Diefenbach, C.
    Rohr, K.
    Stowasser, S.
    Maher, T. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [9] Effect of nintedanib on biomarkers of extracellular matrix (ECM) turnover and FVC decline in patients with IPF: results from the INMARK study
    Pfeifer, M.
    Maher, T. M.
    Stowasser, S.
    Nishioka, Y.
    White, E. S.
    Cottin, V
    Noth, I
    Selman, M.
    Rohr, K. B.
    Wachtlin, D.
    Ittrich, C.
    Diefenbach, C.
    Jenkins, R. G.
    PNEUMOLOGIE, 2020, 74 : S103 - S104
  • [10] BIOMARKERS OF DISEASE PROGRESSION IN ASIAN SUBJECTS WITH IDIOPATHIC PULMONARY FIBROSIS TREATED WITH NINTEDANIB: SUBGROUP ANALYSIS OF THE INMARK TRIAL
    Nishioka, Yasuhiko
    Song, Jin Woo
    Kondoh, Yasuhiro
    Kim, Young Whan
    Nishiyama, Osamu
    Stowasser, Susanne
    Michael, Andreas
    Diefenbach, Claudia
    Rohr, Klaus B.
    Maher, Toby M.
    RESPIROLOGY, 2019, 24 : 83 - 83
12345